Carmella Evans-Molina, MD, PhD, this year’s Outstanding Scientific Achievement Award winner, was first interested in understanding the beta-cell pathways that drive the transition from normoglycemia to dysglycemia to diabetes. Now she is focusing on ways to leverage beta-cell stress to inform type 1 diabetes biomarker development.

DKD may look the same clinically in type 1 diabetes and type 2 diabetes, but research suggests there are differences that could influence risk, progression, and treatment for patients with each type of diabetes. “We are looking into molecular pathways and planning direct comparisons between type 1 diabetes and type 2 diabetes to find altered…

Factors including food insecurity, community, and economic disadvantage play integral roles in the development and care of diabetes, according to four experts who took a closer look at social determinants of health and diabetes. Felicia Hill-Briggs, PhD, ABPP, provided an overview of SDOH in the development of diabetes. She was the chair of the committee…

Nutrient-stimulated hormones have changed the landscape of weight loss recently, and four scientists, including Jonathan Campbell, PhD, presented information about several types of combinations of these therapies that have and are being tested in trials.

In a Monday morning symposium, three scientists spotlighted major advancements in diabetes from the past year, from new guidelines and statements to a bionic pancreas and anti-obesity drugs. John B. Buse, MD, PhD, reported that health equity issues remain the biggest challenge in advancing diabetes treatment and prevention.

Nutrition plays a significant role in a patient’s diabetes management, but there is no universal approach to incorporating a healthy diet. Ka Hei Karen Lau, MS, RDN, LDN, CDCES, and other specialists explored various nutrition programs, such as providing food benefits to those without access to food, offering education on food choices, and addressing weight…

Rodica Busui, MD, PhD, American Diabetes Association® President of Medicine & Science, recalled her earliest days of working in a clinic in Romania, her fellowship at the University of Michigan, and choosing diabetes as her life’s work. She also discussed the new clinical research program in diabetes she was asked to develop.

Alka M. Kanaya, MD, shared clinical implications from her research, Mediators of Atherosclerosis in South Asians Living in America, which aims to understand the factors that lead to diabetes in South Asian populations. South Asian individuals in the U.S. have the highest prevalence of diabetes compared to other racial or ethnic groups.

The work of physician-scientist Matthias H. Tschöp, MD, has transformed the fight against obesity and diabetes. As the Banting Medal for Scientific Achievement honoree, he shared insights into the ongoing quest to reverse obesity, including the possibilities offered by the approval of tirzepatide for the treatment of type 2 diabetes.

Studies harness real-world data for vital insights into patient populations and can help determine the delivery of care for patients with diabetes. Experts, including Kristi Reynolds, PhD, MPH, FAHA, FACE, discussed the utility of real-world data and how having access to electronic health records can help in examining long-term trends.